✨ Your Portfolio is fetched and updated from zerodha.
Micro Agriculture

Shree Ganesh Bio-Tech (India) Ltd.

SHREEGANES

Market Cap
₹38 Cr.
P/E
20.18

Shree Ganesh Bio-Tech (India) Ltd.

  • Shree Ganesh BioTech
  • Shree Oswal Seeds
  • JK Agri Genetics
FAQs on Shree Ganesh Bio-Tech (India) Ltd. Shareprice

Shree Ganesh BioTech has given lower returns compared to its competitors.
Shree Ganesh BioTech has grown at ~-26.45% over the last 6yrs while peers have grown at a median rate of 21.13%

Shree Ganesh BioTech is not expensive.
Latest PE of Shree Ganesh BioTech is 20.18, while 3 year average PE is 173.
Also latest EV/EBITDA of Shree Ganesh BioTech is 0.0 while 3yr average is 513.

View FAQ's On Business
Growth Table
  • Shree Ganesh Bio-Tech (India) Ltd.
  • Shree Oswal Seeds
  • JK Agri Genetics
Balance Sheet
  • Shree Ganesh Bio-Tech (India) Ltd.
  • Shree Oswal Seeds
  • JK Agri Genetics
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Shree Ganesh Bio-Tech (India) Ltd.
  • Shree Oswal Seeds
  • JK Agri Genetics
Cash Flow
  • Shree Ganesh Bio-Tech (India) Ltd.
  • Shree Oswal Seeds
  • JK Agri Genetics
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Shree Ganesh Bio-Tech (India) Ltd.
  • Shree Oswal Seeds
  • JK Agri Genetics
Quarterly Results
  • Shree Ganesh Bio-Tech (India) Ltd.
  • Shree Oswal Seeds
  • JK Agri Genetics
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Shree Ganesh Bio-Tech (India) Ltd. Financials

Balance sheet of Shree Ganesh BioTech is moderately strong, But short term working capital might become an issue for this company.

Yes, The debt of Shree Ganesh BioTech is increasing.
Latest debt of Shree Ganesh BioTech is -₹0.01 Crs as of Sep-24.
This is greater than Mar-24 when it was -₹0.85 Crs.

The profit is oscillating.
The profit of Shree Ganesh BioTech is ₹1.88 Crs for TTM, ₹0.62 Crs for Mar 2024 and ₹2.04 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Shree Ganesh BioTech latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech